middle.news
How ReNerve’s 53% Revenue Surge Signals a New Era in Global Nerve Repair
2:36pm on Wednesday 30th of July, 2025 AEST
•
Healthcare
Read Story
How ReNerve’s 53% Revenue Surge Signals a New Era in Global Nerve Repair
2:36pm on Wednesday 30th of July, 2025 AEST
Key Points
53% year-on-year revenue growth to $271k in FY25
Strategic partnership with Berkeley Biologics to launch dermal and amniotic tissue products in the US
Regulatory approval for NervAlign® Nerve Cuff in Bahrain marks MENA market entry
Partnership with NetCentrix Ventures to pursue Indian market regulatory approval and commercialization
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Renerve (ASX:RNV)
OPEN ARTICLE